July 14,2006

Chairman Grassley Questions CMS, FDA About Substituted Inhalation Drugs

Please see the printer-friendly version of Chairman Grassley's letter CMS and FDA regarding substituted inhalation drugs.

Next Article Previous Article

Recent News

09/13/21 Crapo, Brady Introduce Bill to Protect Taxpayer Rights and Privacy
09/10/21 Senate Democrats’ International Tax Proposal Receives Overwhelmingly Negative Feedback from U.S. Manufacturers and Innovators
09/09/21 Democrats’ Tax Hikes Let China Win
09/07/21 Finance Committee Republicans Demand Full, Open Process to Vet Reckless Tax-and-Spend Proposals
09/02/21 Crapo, Brady Warn Administration’s OECD Position Undermines Congress’s Authority over U.S. Tax Law